Q56.3
Pseudohermaphroditism, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Pseudohermaphroditism is a condition involving atypical development of sexual characteristics, where an individual has biological sex characteristics that do not match typical male or female patterns. This condition can affect one’s physical appearance and reproductive system, leading to variations in the development of gonads, external genitalia, and secondary sexual characteristics. The term 'unspecified' indicates that the specific details regarding the individual's sex development are not detailed or classified within this diagnosis.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting sex chromosome or gonadal development Hormonal imbalances during fetal development Disorders of sex development (DSDs) such as mixed gonadal dysgenesis or ovotesticular DSD Exposure to external factors that disrupt hormone production during pregnancy Certain endocrine or metabolic disorders that influence sexual differentiation
Key Symptoms: Presence of ambiguous or atypical external genitalia Inconsistent or mismatched secondary sexual characteristics Variations in gonadal development, such as ovotestes or dysgenetic gonads Differences in hormone levels detectable through laboratory testing Potential fertility issues or reproductive difficulties
Diagnostic & Treatment
Diagnosis Path: Diagnosing pseudohermaphroditism involves a combination of physical examinations, hormonal assessments, and genetic testing. The process typically includes:
Treatment Protocols: Management of pseudohermaphroditism aims to address physical development, hormone balance, and psychological well-being. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is Q56.3 a billable ICD-10 code?
Yes, Q56.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q56.3?
Clinical documentation must specify the nature of Pseudohermaphroditism, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference